Potential COVID-19 therapeutics from a rare disease: weaponizing lipid dysregulation to combat viral infectivity-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Potential COVID-19 therapeutics from a rare disease: weaponizing lipid dysregulation to combat viral infectivity

Published:2020-07 Issue:7 Volume:61 Page:972-982
ISSN:0022-2275
Container-title:Journal of Lipid Research
language:en
Short-container-title:Journal of Lipid Research

Author:

Sturley Stephen L.,Rajakumar Tamayanthi,Hammond Natalie,Higaki Katsumi,Márka Zsuzsa,Márka Szabolcs,Munkacsi Andrew B.

Funder

Ara Parseghian Medical Research Foundation

Actelion Pharmaceuticals Ltd

National Institutes of Health

Wellington Medical Research Foundation

Charles H. Revson Foundation

Publisher

Elsevier BV

Subject

Cell Biology,Endocrinology,Biochemistry

Reference118 articles.

1. An interactive web-based dashboard to track COVID-19 in real time;Dong;Lancet Infect. Dis.,2020

2. Lam, T. T., M. H., Shum, H. C., Zhu, Y. G., Tong, X. B., Ni, Y. S., Liao, W., Wei, W. Y., Cheung, W. J., Li, L. F., Li, . Identifying SARS-CoV-2 related coronaviruses in Malayan pangolins. Nature. Epub ahead of print. March 26, 2020; doi:10.1038/s41586-020-2169-0.

3. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan;Chan;Emerg. Microbes Infect.,2020

4. Systematic comparison of two animal-to-human transmitted human coronaviruses: SARS-CoV-2 and SARS-CoV;Xu;Viruses.,2020

5. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor;Hoffmann;Cell.,2020

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bafilomycin A1 Inhibits HIV-1 Infection by Disrupting Lysosomal Cholesterol Transport;Viruses;2024-08-29

2. Cholesterol and COVID-19—therapeutic opportunities at the host/virus interface during cell entry;Life Science Alliance;2024-02-22

3. Targeting the mammalian target of rapamycin pathway in neurological manifestations of Covid‐19;Reviews in Medical Virology;2023-12-29

4. An overview of the role of Niemann-pick C1 (NPC1) in viral infections and inhibition of viral infections through NPC1 inhibitor;Cell Communication and Signaling;2023-12-14

5. Inactivation of the Niemann Pick C1 cholesterol transporter 1 (NPC1) restricts SARS-CoV-2 infection;2023-12-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3